CanSAGE Logo

Sponsored Symposia

Thursday, October 1, 2026

12:30 – 13:15

Room 2000AB

Hologic Lunch Symposium – The Modern Fibroid Toolkit: Guideline Based Care from Hysteroscopic Resection to Transcervical and Laparoscopic Ablation

Moderator: TBD
Speaker: Darrien Rattray

Non-accredited session

Session details

Sponsored by:

Learning Objectives:

  • Review key updates from the most recent SOGC guideline on uterine fibroid management and their implications for MIGS practice.
  • Describe a minimally invasive continuum of care for symptomatic fibroids, from diagnosis and patient selection to uterine preserving procedural options.
  • Differentiate treatment strategies based on fibroid type, size, and location, including submucosal, intramural, and transmural disease.
  • Evaluate the role of hysteroscopic tissue removal using MyoSure for management of intrauterine fibroids within guideline supported treatment pathways.
  • Assess transcervical and laparoscopic fibroid ablation technologies (Sonata and Acessa) and their role in treating fibroids not amenable to hysteroscopic management.
  • Integrate multiple minimally invasive technologies into a patient centered treatment algorithm that preserves the uterus and expands surgical options for women with fibroids.

Friday, October 2, 2026

07:15 – 08:00

Room 206AB

Knight Therapeutics Breakfast Symposium – Medical Management of Fibroids and Adenomyosis: Where Do GnRH Antagonists Fit?

Moderator: Valérie To
Speaker: Cleve Ziegler

Non-accredited session

Session details

Sponsored by:

11:15 – 12:00

Room 206AB

AbbVie Lunch Symposium

Moderator: TBD
Speaker: TBD

Non-accredited session

Session details

Sponsored by:


Saturday, October 3, 2026

12:00 – 12:45

Room 206AB

Pharmacosmos Canada Lunch Symposium – Why Are We Still Operating on Anaemic Patients? Rethinking Iron Deficiency Pathways in Gynaecology

Moderator: Kristina Arendas
Speaker: Ryan Lett

Non-accredited session

Session details

Sponsored by:

Learning Objectives:

  • Describe the impact of iron deficiency and anemia on surgical readiness and perioperative outcomes in gynecology.
  • Differentiate key practical considerations among IV iron options, including dosing burden, need for repeat infusions, and phosphate monitoring considerations.
  • Assess the clinical importance of complete iron repletion and the limitations of a fixed 1000 mg approach for all patients.
  • Apply pathway-based strategies to improve pre-operative management of iron deficiency in gynecologic practice.